Jiangsu Hansoh Pharmaceutical Group Competitors and Similar CompaniesClear all

Jiangsu Hansoh Pharmaceutical Group's competitors and similar companies include Yabao Pharmaceutical, Takeda, CureVac and PLIVA.
Jiangsu Hansoh Pharmaceutical Group
Jiangsu Hansoh Pharmaceutical Group
Jiangsu Hansoh Pharmaceutical Group is a pharmaceutical company.
Yabao Pharmaceutical
Yabao Pharmaceutical
Yabao Pharmaceutical Group ( 亚宝药业) is a company that specializes in the production, logistics, and distribution of medicines.
Takeda
Takeda
Takeda Pharmaceutical is a biopharmaceutical company engaged in the research, development, production, and commercialization of pharmaceutical products.
CureVac
CureVac
CureVac is a biotechnology company offering messenger RNA (mRNA) technology.
PLIVA
PLIVA
PLIVA HRVATSKA is a pharmaceutical company focused on the development of generic and niche products.
Founding Date
Founding Date
1995
Founding Date
1978
Founding Date
1781
Founding Date
2000
Founding Date
1921
Type
Type
Public
Type
Public
Type
Public
Type
Public
Type
Subsidiary
Tags
Locations
Locations
Lianyungang Shi, CN HQ
Locations
Yuncheng Shi, CN HQ
Beijing, CN
Yuncheng, CN
Yuncheng Shi, CN
Locations
Tokyo, JP HQ
Buenos Aires, AR
The Rocks, AU
Linz, AT
Wien, AT
Wien, AT
Lessines, BE
see more
Locations
Tübingen, DE HQ
Ottignies Louvain La Neuve, BE
Wiesbaden, DE
Amsterdam, NL
Basel, CH
Boston, US
Locations
Zagreb, HR HQ
Sarajevo, BA
Skopje, MK
Belgrade, RS
Employees
Employees
9,099
Employees
4,142
Employees
49,281
Employees
999
Employees
1,647
Valuation ($)
Valuation ($)
N/A
Valuation ($)
613.8 m
Valuation ($)
43.7 b
Valuation ($)
648.3 m
Valuation ($)
N/A

Financial

Revenue (est.)
Revenue (est.)
¥10.1b (FY, 2023)
Revenue (est.)
¥2.8b (FY, 2023)
Revenue (est.)
¥4.3t (FY, 2024)
Revenue (est.)
€53.8m (FY, 2023)
Revenue (est.)
N/A
Cost of goods
Cost of goods
¥664.5m (FY, 2023)
Cost of goods
¥1.2b (FY, 2023)
Cost of goods
¥698.7b (FY, 2024)
Cost of goods
€64.3m (FY, 2023)
Cost of goods
N/A
Gross profit
Gross profit
¥9.5b (FY, 2023)
Gross profit
¥1.6b (FY, 2023)
Gross profit
¥3.6t (FY, 2024)
Gross profit
(€2.6m) (FY, 2023)
Gross profit
N/A
Net income
Net income
¥3.3b (FY, 2023)
Net income
¥179.9m (FY, 2023)
Net income
¥144.2b (FY, 2024)
Net income
(€260.2m) (FY, 2023)
Net income
N/A

Funding

Total funding raised
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
$ 57.8m
Total funding raised
$ 1.1b
Total funding raised
N/A
For sources of this data, please see the company profile

View Company Profiles

Yabao Pharmaceutical
HQ
Yuncheng Shi, CN
Employees
4,142

Yabao Pharmaceutical Group ( 亚宝药业) is a company that specializes in the production, logistics, and distribution of medicines.

View company
Takeda
HQ
Tokyo, JP
Employees
49,281

Takeda Pharmaceutical is a biopharmaceutical company engaged in the research, development, production, and commercialization of pharmaceutical products.

View company
CureVac
HQ
Tübingen, DE
Employees
999

CureVac is a biotechnology company offering messenger RNA (mRNA) technology.

View company
PLIVA
HQ
Zagreb, HR

PLIVA HRVATSKA is a pharmaceutical company focused on the development of generic and niche products.

View company